Cannabis UseCANNACYNCT03167021
Survey on the Place of Community Pharmacists in the Detection of Cannabis Use: a Student's Point of View
An observational study of Cannabis Use, run by University Hospital, Clermont-Ferrand at 1 site in France.
Trial summary
The objective of this survey will be to evaluate the perception by the students (except for medical students, pharmacies) of community pharmacists concerning the management of cannabis consumption. Read more about this study
- Who is it for?
- Ages 18 years and olderHealthy volunteers can take part
- Conditions the study is for
- Cannabis Use
- What is being tested?
- Survey
- How many people
- 150 participants
- Where
- 1 siteFrance
- Study dates
- 5 Apr 2017to 2 Jun 2017
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Study population: The young and student populations are particularly affected by the use of addictive substances, including alcohol, tobacco and cannabis. Students of the Auvergne Rhone Alpes region will be contacted by email thanks to the student associations and scolarity departments. Answer to the survey will be done online.
Who may be able to join
- Student following a university path in the Auvergne Rhone Alpes region
Who cannot join
- Medical student
- Pharmacy student
- age < 18-year
- Other than student
Trial locations and contacts
1 site in 1 country.
About this study
The objective of this survey will be to evaluate the perception by the students (except for medical students, pharmacies) of community pharmacists concerning the management of cannabis consumption. We want to see if the student population perceives the pharmacist as the public health actor of choice, and if they would more easily turn to him or to another health professional (doctor, nurse) in case they need. Discussing possible problematic consumption or for a simple search for information. It will be assessed whether the pharmacist seems to be a good candidate and an element of choice when young adults want to take an intelligence approach to cannabis consumption.
Read the detailed description
This observational and transversal study will be conducted as a survey using the REDCap software and the response to this survey will be done online, in real time, with an automatic, secure and centralized data collection (CHU Clermont-Ferrand).
Students of the Auvergne Rhone Alpes region will be contacted by email thanks to the student associations and scholarity departments. Answer to the survey will be done online via the following link https://redcap.chu-clermontferrand.fr/surveys/?s=JMRF9FLRJP.
- Conditions
- Cannabis Use
- Being tested
- Survey
- Keywords
- Cannabis, Community pharmacy, Prevention, Students
- Medical subject headings
- Marijuana Abuse
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
SurveyOther
This observational and transversal study will be conducted as a survey using the REDCap software and the response to this survey will be done online, in real time, with an automatic, secure and centralized data collection (CHU Clermont-Ferrand).
| Study group | Role | What they receive |
|---|---|---|
| Students | Students of the Auvergne Rhone Alpes region will be contacted by email thanks to the student associations and scholarity departments. Answer to the survey will be done online. Receives: Other: Survey |
What is being measured
The primary outcome is the main question the study is designed to answer.
Role of health professionals in the prevention of cannabis addiction
Students' perceptions (visual analogic scale) of the role of three types of health professionals (community pharmacists, general practitioners and academic health services) in the prevention of cannabis addiction
Measured: at day 1
Secondary outcomes (9)
Role of health professionals for the therapeutic management of cannabis addiction
Assessment of students' perceptions (visual analogic scale) of the role of three types of health professionals (community pharmacists, general practitioners and academic health services) for the therapeutic management of cannabis addiction.
Measured: at day 1
Cannabis consumption
yes/no
Measured: at day 1
Type of cannabis used
marijuana/haschich
Measured: at day 1
Frequency of cannabis use
Measured: at day 1
Sought effects of cannabis use
Recreational / Stone / Therapeutic / Other expected effect
Measured: at day 1
Level of knowledge on cannabis
Yes I know the risk / No I don't know the risk
Measured: at day 1
Consumption of cigarettes
yes/no
Measured: at day 1
Consumption of e-cigarettes
yes/no
Measured: at day 1
Consumption of alcohol
yes/no
Measured: at day 1
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted25 May 2017
- Study start5 Apr 2017
- Primary completion2 Jun 2017
- Study completion2 Jun 2017
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Cannabis UseStudies of the same condition, open and under way.
- More trials run by University Hospital, Clermont-FerrandThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Other
- Time perspective
- Prospective
- Enrolment
- 150 participants (actual)
Sponsor and investigators
- Lead sponsor
- University Hospital, Clermont-Ferrand
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT03167021
- Sponsor's protocol ID
- CHU-333
- Other IDs
- 2017-A00328-45
- Acronym
- CANNACY
- Status last verified
- May 2017
- First submitted
- 11 May 2017
- Last updated
- 7 Jul 2017
- Results posted
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 7 Jul 2017. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Survey on the Place of Community Pharmacists in the Detection of Cannabis Use: a Student's Point of View
- ClinicalTrials.gov ID
- NCT03167021
- Acronym / sponsor ID
- CANNACY / CHU-333
- Conditions
- Cannabis Use
- Keywords
- Cannabis, Community pharmacy, Prevention, Students
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 150 participants (actual)
- Lead sponsor
- University Hospital, Clermont-FerrandUniversity, hospital or other
- Study start
- 5 Apr 2017 (actual)
- Primary completion
- 2 Jun 2017 (actual)
- Study completion
- 2 Jun 2017 (actual)
- First posted
- 25 May 2017 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The objective of this survey will be to evaluate the perception by the students (except for medical students, pharmacies) of community pharmacists concerning the management of cannabis consumption. We want to see if the student population perceives the pharmacist as the public health actor of choice, and if they would more easily turn to him or to another health professional (doctor, nurse) in case they need. Discussing possible problematic consumption or for a simple search for information. It will be assessed whether the pharmacist seems to be a good candidate and an element of choice when young adults want to take an intelligence approach to cannabis consumption.
Detailed description
This observational and transversal study will be conducted as a survey using the REDCap software and the response to this survey will be done online, in real time, with an automatic, secure and centralized data collection (CHU Clermont-Ferrand).
Students of the Auvergne Rhone Alpes region will be contacted by email thanks to the student associations and scholarity departments. Answer to the survey will be done online via the following link https://redcap.chu-clermontferrand.fr/surveys/?s=JMRF9FLRJP.
Study design
- Observational model
- Other
- Time perspective
- Prospective
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Students | – | Other: SurveyStudents of the Auvergne Rhone Alpes region will be contacted by email thanks to the student associations and scholarity departments. Answer to the survey will be done online. |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
- Study population
- The young and student populations are particularly affected by the use of addictive substances, including alcohol, tobacco and cannabis. Students of the Auvergne Rhone Alpes region will be contacted by email thanks to the student associations and scolarity departments. Answer to the survey will be done online.
Key inclusion criteria (1 listed)
- Student following a university path in the Auvergne Rhone Alpes region
Key exclusion criteria (4 listed)
- Medical student
- Pharmacy student
- age < 18-year
- Other than student
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| SurveyThis observational and transversal study will be conducted as a survey using the REDCap software and the response to this survey will be done online, in real time, with an automatic, secure and centralized data collection (CHU Clermont-Ferrand). | Other | Students |
Primary outcome
Role of health professionals in the prevention of cannabis addiction
Time frame: at day 1
Students' perceptions (visual analogic scale) of the role of three types of health professionals (community pharmacists, general practitioners and academic health services) in the prevention of cannabis addiction
9 secondary outcomes
Role of health professionals for the therapeutic management of cannabis addiction
Time frame: at day 1
Cannabis consumption
Time frame: at day 1
Type of cannabis used
Time frame: at day 1
Frequency of cannabis use
Time frame: at day 1
Sought effects of cannabis use
Time frame: at day 1
Level of knowledge on cannabis
Time frame: at day 1
Consumption of cigarettes
Time frame: at day 1
Consumption of e-cigarettes
Time frame: at day 1
Consumption of alcohol
Time frame: at day 1
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 7 Jul 2017.
Related trials for Cannabis Use
Not yet recruiting
Substance Use and Media Preferences
Substance Use Behavior, Cannabis Intoxication
RecruitingObservational study
Study of an Oral Fluid Testing Approach
Cannabis Use, Cannabis Intoxication
Active, not recruitingPhase 1
Psilocybin-assisted Treatment for Cannabis Use Disorder
Cannabis Use Disorder
RecruitingObservational study
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
Breast Carcinoma, Colorectal Carcinoma
Not yet recruitingEarly Phase 1
Lung Health and Breath Biomarkers: Acute Effects of Inhaled Cannabis
Cannabis Use, Tobacco
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Cannabis Use, run by University Hospital, Clermont-Ferrand at 1 site in France.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 7 Jul 2017. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Role of health professionals in the prevention of cannabis addiction (time frame: at day 1). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 7 Jul 2017.